Fragile X Syndrome Global Clinical Trials Review, H2, 2011

Request for Sample Pages

Published Date : 30 November 2011

Pages : 69

Add to Cart - Fragile X Syndrome Global Clinical Trials Review, H2, 2011

Fragile X Syndrome Global Clinical Trials Review, H2, 2011

Summary

GlobalDatas clinical trial report, Fragile X Syndrome Global Clinical Trials Review, H2, 2011 provides data on the Fragile X Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fragile X Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fragile X Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents :

List of Tables 4
List of Figures 5
Introduction 6
Fragile X Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Fragile X Syndrome Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Seaside Therapeutics 24
Clinical Trial Overview of Seaside Therapeutics 24
Novartis AG 25
Clinical Trial Overview of Novartis AG 25
Neuropharm Group Plc (Inactive) 26
Clinical Trial Overview of Neuropharm Group Plc (Inactive) 26
Cortex Pharmaceuticals, Inc. 27
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 27
F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of Top Universities / Institutes / Hospitals 29
Stanford University 29
Clinical Trial Overview of Stanford University 29
University of California, Davis 30
Clinical Trial Overview of University of California, Davis 30
Indiana University 31
Clinical Trial Overview of Indiana University 31
The Mediterranean Institute for the Advance of Biotechnology and Health Research 32
Clinical Trial Overview of The Mediterranean Institute for the Advance of Biotechnology and Health Research 32
Fragile X Research Foundation of Canada 33
Clinical Trial Overview of Fragile X Research Foundation of Canada 33
The University of North Carolina 34
Clinical Trial Overview of The University of North Carolina 34
Indiana University School of Medicine 35
Clinical Trial Overview of Indiana University School of Medicine 35
All India Institute of Medical Sciences 36
Clinical Trial Overview of All India Institute of Medical Sciences 36
Massachusetts General Hospital 37
Clinical Trial Overview of Massachusetts General Hospital 37
Rabin Medical Center 38
Clinical Trial Overview of Rabin Medical Center 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69

List of Tables
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Fragile X Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011* 10
Fragile X Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 11
Fragile X Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Fragile X Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 13
Fragile X Syndrome Therapeutics Clinical Trials, G7 Countries, 2011* 14
Fragile X Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 15
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 17
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Fragile X Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Fragile X Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Fragile X Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Fragile X Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 23
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Seaside Therapeutics, 2011* 24
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 25
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuropharm Group Plc (Inactive), 2011* 26
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2011* 27
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011* 28
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011* 29
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2011* 30
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2011* 31
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The Mediterranean Institute for the Advance of Biotechnology and Health Research, 2011* 32
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fragile X Research Foundation of Canada, 2011* 33
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2011* 34
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2011* 35
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2011* 36
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011* 37
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2011* 38

List of Figures
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Fragile X Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 11
Fragile X Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Fragile X Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2011* 14
Fragile X Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 15
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 17
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Fragile X Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Fragile X Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Fragile X Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Fragile X Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 23
GlobalData Methodology 67

Published By : GlobalData

PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports
Korea Research Reports
Mexico Research Reports
Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports
Singapore Research Reports
Switzerland Research Reports
UK Research Reports
USA Research Reports
UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company